122 related articles for article (PubMed ID: 37070911)
1. Role of cited-1 and caspase-6 expression in HELLP syndrome.
Öcal E; Alkan Akalın S; Aşır F
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3082-3087. PubMed ID: 37070911
[TBL] [Abstract][Full Text] [Related]
2. Role of SOX9 and Hif-1α expression in placentas of patients with HELLP.
Akalın SA; Öcal E; Deveci E
Acta Cir Bras; 2023; 38():e388023. PubMed ID: 37878989
[TBL] [Abstract][Full Text] [Related]
3. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
4. Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnancies.
Jeschke U; Kunert-Keil C; Mylonas I; Hammer A; Schiessl B; Lomba I; Kuhn C; Schulze S; Friese K
Virchows Arch; 2005 Apr; 446(4):360-8. PubMed ID: 15756591
[TBL] [Abstract][Full Text] [Related]
5. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
Stepan H; Leo C; Purz S; Höckel M; Horn LC
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
[TBL] [Abstract][Full Text] [Related]
6. Placental expression of vimentin, desmin and ultrastructural changes in the villi in patients with HELLP syndrome.
Sak ME; Deveci E; Turgut A; Sak S; Evsen MS; Gul T; Kalkanli S
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(7):874-8. PubMed ID: 23640432
[TBL] [Abstract][Full Text] [Related]
7. Human placental macrophages (Hofbauer cells) in severe preeclampsia complicated by HELLP syndrome: immunohistochemistry of chorionic villi.
Evsen MS; Kalkanli S; Deveci E; Sak ME; Ozler A; Baran O; Erdem E; Seker U
Anal Quant Cytopathol Histpathol; 2013 Oct; 35(5):283-8. PubMed ID: 24282909
[TBL] [Abstract][Full Text] [Related]
8. Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.
Szabo S; Mody M; Romero R; Xu Y; Karaszi K; Mihalik N; Xu Z; Bhatti G; Fule T; Hupuczi P; Krenacs T; Rigo J; Tarca AL; Hassan SS; Chaiworapongsa T; Kovalszky I; Papp Z; Than NG
Pathol Oncol Res; 2015 Jul; 21(3):659-68. PubMed ID: 25583406
[TBL] [Abstract][Full Text] [Related]
9. Distribution of sugar residues in human placentas from pregnancies complicated by hypertensive disorders.
Marini M; Bonaccini L; Thyrion GD; Vichi D; Parretti E; Sgambati E
Acta Histochem; 2011 Dec; 113(8):815-25. PubMed ID: 21774970
[TBL] [Abstract][Full Text] [Related]
10. Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?
Karaszi K; Szabo S; Juhasz K; Kiraly P; Kocsis-Deak B; Hargitai B; Krenacs T; Hupuczi P; Erez O; Papp Z; Kovalszky I; Than NG
Placenta; 2019 Jan; 76():30-39. PubMed ID: 30803712
[TBL] [Abstract][Full Text] [Related]
11. Comparison of placental pathology between severe preeclampsia and HELLP syndrome.
Mehrabian F; Mohammadizadeh F; Moghtaderi N; Najafian A
Arch Gynecol Obstet; 2012 Jan; 285(1):175-81. PubMed ID: 21698449
[TBL] [Abstract][Full Text] [Related]
12. Placental apoptosis in preeclampsia, intrauterine growth retardation, and HELLP syndrome: an immunohistochemical study with caspase-3 and bcl-2.
Cali U; Cavkaytar S; Sirvan L; Danisman N
Clin Exp Obstet Gynecol; 2013; 40(1):45-8. PubMed ID: 23724505
[TBL] [Abstract][Full Text] [Related]
13. Seven placental transcripts characterize HELLP-syndrome.
Buimer M; Keijser R; Jebbink JM; Wehkamp D; van Kampen AH; Boer K; van der Post JA; Ris-Stalpers C
Placenta; 2008 May; 29(5):444-53. PubMed ID: 18374411
[TBL] [Abstract][Full Text] [Related]
14. Total bile acids in the maternal and fetal compartment in relation to placental ABCG2 expression in preeclamptic pregnancies complicated by HELLP syndrome.
Jebbink J; Veenboer G; Boussata S; Keijser R; Kremer AE; Elferink RO; van der Post J; Afink G; Ris-Stalpers C
Biochim Biophys Acta; 2015 Jan; 1852(1):131-6. PubMed ID: 25446997
[TBL] [Abstract][Full Text] [Related]
15. Severe preeclampsia with and without HELLP differ with regard to placental pathology.
Vinnars MT; Wijnaendts LC; Westgren M; Bolte AC; Papadogiannakis N; Nasiell J
Hypertension; 2008 May; 51(5):1295-9. PubMed ID: 18362224
[TBL] [Abstract][Full Text] [Related]
16. Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction.
Langbein M; Strick R; Strissel PL; Vogt N; Parsch H; Beckmann MW; Schild RL
Mol Reprod Dev; 2008 Jan; 75(1):175-83. PubMed ID: 17546632
[TBL] [Abstract][Full Text] [Related]
17. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
Fruscalzo A; Schmitz R; Klockenbusch W; Köhler G; Londero AP; Siwetz M; Huppertz B
Histochem Cell Biol; 2012 Dec; 138(6):925-32. PubMed ID: 22847813
[TBL] [Abstract][Full Text] [Related]
18. Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome.
Marusic J; Prusac IK; Tomas SZ; Karara JR; Roje D
J Matern Fetal Neonatal Med; 2013 May; 26(7):680-5. PubMed ID: 23131093
[TBL] [Abstract][Full Text] [Related]
19. Transient CD15-positive endothelial phenotype in the human placenta correlates with physiological and pathological fetoplacental immaturity.
Seidmann L; Suhan T; Unger R; Gerein V; Kirkpatrick CJ
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():172-9. PubMed ID: 25043745
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia.
Prusac IK; Zekic Tomas S; Roje D
Acta Obstet Gynecol Scand; 2011 Oct; 90(10):1157-63. PubMed ID: 21501125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
